Sharda Cropchem Ltd Q3 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/e0g0eijwk0q8zdidelikxgyn.pdf

Key Takeaways


Revenue Growth & Regional Dynamics

Bubna: "We have passed through a very bad time about 2 years back when there was excess liquidity and abundance of stocks in the pipeline. Those have dried up. And as the things are getting normalized, the prices are also moving. The speed is less, but it is moving up."

Margin Trajectory & Profitability


Working Capital & Balance Sheet


Product Registrations: The Moat & The Uncertainty

Bubna: "To give you an example, a registration may be obtained in 1 year or 2 years, and the same registration can take 6 to 7 years because of the uncertainties. The government authorities keep..."

China Sourcing & Competitive Dynamics

Bubna: "The only thing I can say that China does give some incentives to the Chinese citizens for export. Now how much and what is their policy and what is the variation, it's very difficult to gather and it doesn't affect us. Do you understand?"

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growthAround 15% to 20% total revenue growthFY27
Volume growthConfident 15% volume growth is achievableFY27
Gross marginSustainable at 35%; may go up furtherFY27
EBITDA marginIn range of 18% to 20%FY27
CapexIn range of ₹450 crores to ₹500 croresFY27
Tax rateAnnual tax rate in range of 18% to 20%Ongoing
Q4 momentumExpect similar volume and pricing growth to continueQ4 FY26

Key Metrics

MetricQ3 FY26
Revenue₹1,289 cr, +39% YoY
Agrochemical segment revenue₹1,141 cr, +48% YoY
Non-agrochemical segment revenue₹148 cr, -8.1% YoY
Overall volume growth14% YoY
Agrochemical segment volume growth~15% YoY
Gross margin34.9%, +220 bps YoY
EBITDA₹245.5 cr, +59% YoY
EBITDA margin19.1%
PAT₹145.1 cr, +366% YoY
Forex impactLoss of ₹4.53 cr, on foreign currency payable realignment
Revenue growth bridge38.7% total growth: volume +14.4%, forex +12.6%, price/mix +11.6%
Working capital days70 days, improved 48 days vs March 2025 and 28 days vs Dec 2024
Cash and bank liquid investments₹826 cr as on 31 Dec 2025
Capex (9M FY26)₹399 cr
Planned capex (FY26)₹500 cr
Total product registrations3,004 as on 31 Dec 2025
Registration applications in pipeline1,076
Interim dividend₹6 per share
FY26 revenue growth guidance20%, maintained
FY26 EBITDA margin guidance18% to 20%
FY27 volume growth expectation15%, confident of achieving
FY27 capex guidance₹450 cr to ₹500 cr
FY27 revenue growth expectation15% to 20%
Top 10 products revenue share~43%
Top 10 dealers revenue share~16% to 17%, similar to last year